US equities
|
NVDA
$150.81
▼-2.99%
MU
$697.68
▼-2.07%
AMD
$522.72
▲+3.84%
SPCX
$143.82
▲+1.50%
SNDK
$770.97
▼-3.30%
AMZN
$266.63
▲+3.39%
TSLA
$383.77
▲+0.96%
AAPL
$352.30
▲+0.11%
NVDA
$150.81
▼-2.99%
MU
$697.68
▼-2.07%
AMD
$522.72
▲+3.84%
SPCX
$143.82
▲+1.50%
SNDK
$770.97
▼-3.30%
AMZN
$266.63
▲+3.39%
TSLA
$383.77
▲+0.96%
AAPL
$352.30
▲+0.11%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Prof/ Raphael Mechoulam
Recent news which mentions Prof/ Raphael Mechoulam
Hebrew University, Cannabis Accelerator Collaborate To Advance Medical Marijuana Research
January 26, 2022
Tags
General
Prof/ Yossi Tam
Market News
From
Benzinga
EXCLUSIVE: 180 Life Sciences Identifies New Patentable CBD Analog For Drug Development For Treating Inflammation, Pain
July 28, 2021
Tickers
ATNF
Tags
Market News
Prof/ Raphael Mechoulam
Benzinga
From
Benzinga